You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SMARCA4-deficient primary CNS malignant tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)

Recruiting
  • Atypical Teratoid/Rhabdoid Tumor
  • +17 more
  • Atezolizumab
  • +7 more
  • Birmingham, Alabama
  • +19 more
Feb 2, 2023

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

Recruiting
  • Diffuse Midline Glioma (DMG)
  • +7 more
  • ONC206
  • Standard of Care Radiation Therapy
  • San Francisco, California
  • +2 more
Sep 13, 2022

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial

Active, not recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +10 more
  • FACT Complex-targeting Curaxin CBL0137
  • Birmingham, Alabama
  • +19 more
Jun 29, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,

Active, not recruiting
Has Results
  • Recurrent Lymphoma
  • +5 more
  • Birmingham, Alabama
  • +19 more
Oct 20, 2022

Solid Tumors, CNS Tumors Trial in Worldwide (Entrectinib)

Recruiting
  • Solid Tumors
  • CNS Tumors
  • Orange, California
  • +38 more
Aug 24, 2022

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

Completed
  • Neurofibromatosis Type 1
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Los Angeles, California
  • +11 more
Apr 22, 2022

Clinical, Radiological, Histologic and Molecular Features

Recruiting
  • Meningeal Melanocytoma
  • +3 more
    • Nancy, France
      Nancy University Hospital Center
    Jul 31, 2023

    Glioblastoma, IDH-wildtype, Metformin, Malignancies Trial in Milan (Metformin)

    Not yet recruiting
    • Glioblastoma, IDH-wildtype
    • +2 more
    • Milan, Italy
      Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
    Jun 26, 2023

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023

    Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

    Active, not recruiting
    • Cholangiocarcinoma
    • +5 more
    • Gilbert, Arizona
    • +57 more
    Jan 5, 2022

    Rare Embryonal Tumors of Central Nervous System: International

    Not yet recruiting
    • Embryonal Tumor
      • Yerevan, Armenia
        Hematology Center named after prof. R. Yeolyan
      Jan 25, 2023

      Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

      Not yet recruiting
      • Rhabdoid Tumor
      • +3 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Jul 11, 2023

      Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive

      Recruiting
      • Medulloblastoma
      • Central Nervous System Embryonal Tumors
      • Birmingham, Alabama
      • +61 more
      Feb 16, 2022

      CNS Germinoma, CNS Tumor, Asian Consortium Trial in Goyang-si (Radiation Therapy)

      Recruiting
      • CNS Germinoma
      • +2 more
      • Radiation Therapy
      • Goyang-si, Gyeonggi-do, Korea, Republic of
        National Cancer Center, Korea
      Aug 7, 2023

      Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

      Completed
      • Childhood Solid Neoplasm
      • +4 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Birmingham, Alabama
      • +20 more
      Apr 12, 2021

      Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

      Recruiting
      • Brain Tumor, Primary
      • Blood, CSF and tumor samples
      • Milan, Italy
        IRCCS San Raffaele Scientific Institute
      Mar 16, 2023

      Tissue Collection for Drug Screening and Bioanalysis

      Recruiting
      • Pediatric Central Nervous System Tumor
      • Central Nervous System Tumor
        • New York, New York
          Weill Cornell Medicine
        Nov 28, 2022

        Rare CNS Tumors Outcomes &Risk

        Recruiting
        • High Grade Meningioma
        • +4 more
          • Bethesda, Maryland
            National Cancer Institute (NCI)
          Jul 6, 2022